Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Exploratory Study of [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma

NCT04989959 is registered in ClinicalTrials.gov with Orhan Kemal Oz as lead sponsor.

NCT NCT04989959
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04989959 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Exploratory Study of [18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Lead sponsor
Orhan Kemal Oz
Phase
Phase 1
Overall status
Recruiting
Start date
August 18, 2021
Completion date
August 18, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clear cell renal cell carcinoma, renal cell carcinoma